Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-12-07

FDA Approved: EXCEDRIN MIGRAINE GELTABS — Supplemental Application (Haleon US Holdings LLC)

View source ↗

Summary

FDA approved a supplemental NDA for Excedrin Migraine GelTabs (acetaminophen, aspirin, caffeine) from Haleon US Holdings LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acetaminophen (Acetaminophen)
  • Aspirin (Aspirin)
  • Caffeine (caffeine)

Snippet

SUPPL AP for EXCEDRIN MIGRAINE GELTABS (ACETAMINOPHEN, ASPRIN, CAFFEINE)